Public Market
PersonMentions
0
Relationships
0
Events
0
Documents
0
Also known as:
Public Markets
Public Market/Acquirer
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.
No documents found for this entity.
Total Received
$0.00
0 transactions
Total Paid
$2,150,000,005.70
10 transactions
Net Flow
-$2,150,000,005.70
10 total transactions
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| N/A | Paid | Public Market | New Leaf (NLV-II) | $2.50 | Exit of Acadia Pharmaceuticals investment at 2.... | View |
| N/A | Paid | Public Market | New Leaf (NLV-II) | $3.20 | Exit of InterCept Pharmaceuticals investment at... | View |
| 2017-09-30 | Paid | Public Market | TSXV Listed Canna... | $334,000,000.00 | Capital Raised by Canadian Publicly Traded Cann... | View |
| 2017-09-30 | Paid | Public Market | TSX Listed Cannab... | $403,000,000.00 | Capital Raised by Canadian Publicly Traded Cann... | View |
| 2017-09-30 | Paid | Public Market | CSE Listed Cannab... | $319,000,000.00 | Capital Raised by Canadian Publicly Traded Cann... | View |
| 2017-09-30 | Paid | Public Market | Total Canadian Ca... | $1,056,000,000.00 | Total Capital Raised by Canadian Publicly Trade... | View |
| 2013-04-01 | Paid | Public Market | Chimerix/NLV-II | $0.00 | IPO | View |
| 2012-07-01 | Paid | Public Market | Durata Therapeutics | $0.00 | IPO | View |
| 2011-11-01 | Paid | Public Market | Synageva BioPharm... | $0.00 | Reverse merger to become public; exited at 7.3x | View |
| 1995-01-01 | Paid | Public Market | Maxis | $38,000,000.00 | Maxis went public with revenue of US$38 million | View |
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity